BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26085098)

  • 1. Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.
    Plotkin LI; Gortazar AR; Davis HM; Condon KW; Gabilondo H; Maycas M; Allen MR; Bellido T
    J Biol Chem; 2015 Jul; 290(31):18934-42. PubMed ID: 26085098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocyte Apoptosis Caused by Hindlimb Unloading is Required to Trigger Osteocyte RANKL Production and Subsequent Resorption of Cortical and Trabecular Bone in Mice Femurs.
    Cabahug-Zuckerman P; Frikha-Benayed D; Majeska RJ; Tuthill A; Yakar S; Judex S; Schaffler MB
    J Bone Miner Res; 2016 Jul; 31(7):1356-65. PubMed ID: 26852281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
    Plotkin LI; Bivi N; Bellido T
    Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.
    Aguirre JI; Plotkin LI; Stewart SA; Weinstein RS; Parfitt AM; Manolagas SC; Bellido T
    J Bone Miner Res; 2006 Apr; 21(4):605-15. PubMed ID: 16598381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocyte RANKL Drives Bone Resorption in Mouse Ligature-Induced Periodontitis.
    Kittaka M; Yoshimoto T; Levitan ME; Urata R; Choi RB; Teno Y; Xie Y; Kitase Y; Prideaux M; Dallas SL; Robling AG; Ueki Y
    J Bone Miner Res; 2023 Oct; 38(10):1521-1540. PubMed ID: 37551879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging.
    Davis HM; Pacheco-Costa R; Atkinson EG; Brun LR; Gortazar AR; Harris J; Hiasa M; Bolarinwa SA; Yoneda T; Ivan M; Bruzzaniti A; Bellido T; Plotkin LI
    Aging Cell; 2017 Jun; 16(3):551-563. PubMed ID: 28317237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
    Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed electromagnetic fields regulate osteocyte apoptosis, RANKL/OPG expression, and its control of osteoclastogenesis depending on the presence of primary cilia.
    Wang P; Tang C; Wu J; Yang Y; Yan Z; Liu X; Shao X; Zhai M; Gao J; Liang S; Luo E; Jing D
    J Cell Physiol; 2019 Jul; 234(7):10588-10601. PubMed ID: 30422320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pannexin-1 and P2X7-Receptor Are Required for Apoptotic Osteocytes in Fatigued Bone to Trigger RANKL Production in Neighboring Bystander Osteocytes.
    Cheung WY; Fritton JC; Morgan SA; Seref-Ferlengez Z; Basta-Pljakic J; Thi MM; Suadicani SO; Spray DC; Majeska RJ; Schaffler MB
    J Bone Miner Res; 2016 Apr; 31(4):890-9. PubMed ID: 26553756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice.
    Weinstein RS; O'Brien CA; Almeida M; Zhao H; Roberson PK; Jilka RL; Manolagas SC
    Endocrinology; 2011 Sep; 152(9):3323-31. PubMed ID: 21771887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.
    Bivi N; Condon KW; Allen MR; Farlow N; Passeri G; Brun LR; Rhee Y; Bellido T; Plotkin LI
    J Bone Miner Res; 2012 Feb; 27(2):374-89. PubMed ID: 22028311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling.
    Qu X; Mei J; Yu Z; Zhai Z; Qiao H; Dai K
    Biochem Biophys Res Commun; 2018 Jun; 501(2):547-555. PubMed ID: 29746861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.
    Xiong J; Piemontese M; Thostenson JD; Weinstein RS; Manolagas SC; O'Brien CA
    Bone; 2014 Sep; 66():146-54. PubMed ID: 24933342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
    Wu Q; Zhou X; Huang D; Ji Y; Kang F
    Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
    Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
    J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
    Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
    Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL subcellular trafficking and regulatory mechanisms in osteocytes.
    Honma M; Ikebuchi Y; Kariya Y; Hayashi M; Hayashi N; Aoki S; Suzuki H
    J Bone Miner Res; 2013 Sep; 28(9):1936-49. PubMed ID: 23529793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.